Since radioresistance is a major cause that leads to the poor outcomes of NPC patients, we analyzed the ability of USP5 and EphA2 to predict disease free survival (DFS) and overall survival (OS) of the patients. The gene discussed is EPHA2; the disease is nasopharyngeal carcinoma.